Francois Nader - Net Worth and Insider Trading
Francois Nader Net Worth
The estimated net worth of Francois Nader is at least $129,110 dollars as of 2024-11-13. Francois Nader is the Director of Talaris Therapeutics Inc and owns about 47,467 shares of Talaris Therapeutics Inc (TALS) stock worth over $129,110. Details can be seen in Francois Nader's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Francois Nader has not made any transactions after 2022-07-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Francois Nader
Francois Nader Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Francois Nader owns 7 companies in total, including Prevail Therapeutics Inc (PRVL) , Alexion Pharmaceuticals Inc (ALXN) , and Moderna Inc (MRNA) among others .
Click here to see the complete history of Francois Nader’s form 4 insider trades.
Insider Ownership Summary of Francois Nader
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PRVL | Prevail Therapeutics Inc | 2020-06-17 | director |
| ALXN | Alexion Pharmaceuticals Inc | 2020-05-14 | director |
| MRNA | Moderna Inc | 2019-12-10 | director |
 | | 2020-01-22 | director |
| | 2016-06-03 | director |
| | 2014-01-30 | director |
| | 2022-07-21 | director |
Francois Nader Latest Holdings Summary
Francois Nader currently owns a total of 1 stock. Francois Nader owns 47,467 shares of Talaris Therapeutics Inc (TALS) as of July 21, 2022, with a value of $129,110.
Latest Holdings of Francois Nader
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TALS | Talaris Therapeutics Inc | 2022-07-21 | 47,467 | 2.72 | 129,110 |
Holding Weightings of Francois Nader
Francois Nader Form 4 Trading Tracker
According to the SEC Form 4 filings, Francois Nader has made a total of 2 transactions in Talaris Therapeutics Inc (TALS) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Talaris Therapeutics Inc is the acquisition of 13,850 shares on July 21, 2022, which cost Francois Nader around $499,985.
Insider Trading History of Francois Nader
- 1
Francois Nader Trading Performance
GuruFocus tracks the stock performance after each of Francois Nader's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Francois Nader is -62.23%. GuruFocus also compares Francois Nader's trading performance to market benchmark return within the same time period. The performance of stocks bought by Francois Nader within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Francois Nader's insider trading performs compared to the benchmark.
Performance of Francois Nader
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 8.51 | | | | | |
| Relative Return to S&P 500(%) | 2.77 | | | | | |
Francois Nader Ownership Network
Ownership Network List of Francois Nader
Ownership Network Relation of Francois Nader
Francois Nader Owned Company Details
What does Prevail Therapeutics Inc do?
Who are the key executives at Prevail Therapeutics Inc?
Francois Nader is the director of Prevail Therapeutics Inc. Other key executives at Prevail Therapeutics Inc include director & 10 percent owner Carl L Gordon , director & 10 percent owner Peter A. Thompson , and General Counsel Kira M. Schwartz .
Prevail Therapeutics Inc (PRVL) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Prevail Therapeutics Inc (PRVL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Prevail Therapeutics Inc (PRVL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Prevail Therapeutics Inc (PRVL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Prevail Therapeutics Inc Insider Transactions
Francois Nader Mailing Address
Above is the net worth, insider trading, and ownership report for Francois Nader. You might contact Francois Nader via mailing address: 550 Hills Drive, Bedminster Nj 07921.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
